论文部分内容阅读
目的：探讨应用经皮穿刺清理棘球蚴内囊子囊及囊内坏死组织，并对囊腔胆瘘进行处理。方法：采用我们自行设计的专用器械———扩张型多功能套管式穿刺针ＤＭＦＴ（ＤｉｌａｔａｂｌｅＭｕｌｔｙＦｕｎｃｔｉｏｎＴｒｏｃａｒ）对腹腔棘球蚴病应用经皮穿刺引流与刮吸治疗（ＰＰＤＣ，ＰｅｒｃｕｔａｎｅｏｕｓＰｕｎｃｔｕｒｅＤｒａｉｎａｇｅａｎｄＣｕｒｅｔａｇｅ）１１０６例（１２６２个囊肿），包括并发症型棘球蚴囊肿、单囊多房型及多子囊型棘球蚴囊肿。结果：治疗后６个月，Ｂ超显示囊肿缩小与不能辨认者为９５％（９２３／９７１）、１年时为９４％（７２５／７７３）、３年时囊肿完全消失、无法辨认、缩小与停止生长者总计达９３％（４１６／４４９）。穿刺成功率９８％，复发率及并发症发生率明显较手术治疗低。结论：采用ＰＰＤＣ法治疗肝腹腔棘球蚴囊肿可获得类同于手术治疗的满意疗效。适用于大多数囊型棘球蚴病患者，结合化疗药物对多发型棘球蚴病患者也不失为一种新的治疗方法
Objective: To explore the application of percutaneous puncture of cystic echinococcosis cyst and necrotic tissue, and cystic fistula for treatment. Methods: We used the self-designed special instrument --- DFT (DFT-MDT) to treat peritoneal hydatidosis by percutaneous puncture drainage and cure (PPDC) 1106 Cases (1262 cysts), including complications of hydatid cyst, single-capsule multi-chamber type and multiple ascocysts hydatid cyst. Results: At 6 months after treatment, cysts were 95% (923/97) in patients with cystic degeneration and inability to be identified and 94% (725/773) in 1 year. The cysts disappeared completely at 3 years and were not identifiable Total cessation of growth amounted to 93% (416/449). Puncture success rate of 98%, the recurrence rate and complication rate was significantly lower than the surgical treatment. Conclusion: The treatment of hepatic and peritoneal hydatid cysts by PPDC can achieve the same therapeutic effect. For most patients with cystic echinococcosis, combined with chemotherapy drugs for patients with multiple hydatid disease is also a new treatment